查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1863096

血管內超音波市場按應用、類型、最終用途和手術方式分類－2025-2032年全球預測

Intravascular Ultrasound Market by Application, Type, End Use, Procedure - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，血管內超音波市場將成長至 13.8066 億美元，複合年成長率為 5.33%。

關鍵市場統計數據
基準年 2024 9.1095億美元
預計年份：2025年 9.592億美元
預測年份 2032 13.8066億美元
複合年成長率 (%) 5.33%

本文概述了血管內超音波技術的發展歷程及其在現代心血管護理中對手術決策和器械選擇的影響，並闡述了其在臨床應用中的臨床意義。

血管內超音波（IVUS）已從研究輔助手段發展成為第一線影像技術，對介入治療策略和器械選擇產生重大影響。聲學陣列技術、高解析度成像模式和導管設計的進步縮小了血管內成像與即時手術指導之間的差距，使臨床醫生能夠更自信地觀察血管形態、量化斑塊負荷並最佳化器械尺寸。因此，IVUS在複雜的冠狀動脈和周邊血管介入治療中發揮日益重要的作用，有助於提高手術精度並可能改善臨床療效。

在醫療保健領域，臨床證據、操作人員培訓和設備可用性共同推動了血管內超音波（IVUS）技術的應用。與其他互補模式的技術協同作用、支援自動化測量的軟體分析以及與導管室工作流程的整合，正在塑造臨床醫生的預期。同時，監管和報銷途徑也持續影響採購選擇和實施策略。綜上所述，這些因素正使IVUS成為相關人員尋求利用成像技術來提升自身價值提案的臨床和商業性焦點。

高解析度影像、軟體自動化和臨床證據產生技術的變革性融合，正在重新定義血管內超音波在介入治療規劃中的作用。

技術創新、不斷完善的臨床指南以及對手術結果的新期望共同重塑了血管內超音波（IVUS）的模式。射頻陣列導管和改進的訊號處理演算法能夠更清晰地顯示斑塊成分和支架阻塞情況，從而減少對透視影像推斷的依賴。同時，功能更強大的軟體套件能夠自動測量管腔和斑塊，使操作者能夠快速解讀結果並產生一致的報告，從而支援標準化的手術終點和結果對比分析。

此外，手術流程的重點正從單純的解剖學成功轉向功能和耐久性指標，這促使臨床醫生將血管內超音波（IVUS）觀察與生理評估和術中決策相結合。這種轉變促使供應商提供可與現有導管室系統互通性的平台，並支援資料匯出以用於註冊和長期追蹤。同時，設備製造商、軟體開發人員和臨床中心之間建立的夥伴關係生態系統正在加速實證醫學證據的產生和應用。這些變革性的變化正在從臨床、營運和商業性重新定義IVUS的價值提案。

評估2025年美國關稅變化對血管內超音波相關人員的供應鏈重組、採購多元化和替代商業模式的影響

2025年美國關稅調整和貿易政策變化對醫療影像硬體和一次性醫療器材的採購、供應鏈和定價策略產生了複雜的影響。對於依賴精密設計的導管、客製化換能器材料和主機電子元件的血管內超音波（IVUS）而言，進口關稅的增加可能導致到岸成本上升。為此，製造商正優先考慮區域採購多元化、關鍵零件的近岸生產以及設計改進，以減少對受關稅影響的原料的依賴，同時保持臨床性能。

供應鏈轉型不會立即發生，認證、檢驗和監管備案的前置作業時間會造成時間上的摩擦。因此，醫療服務提供者正在採取分階段籌資策略和長期服務合約來緩解價格波動。同時，經銷商和原始設備製造商 (OEM) 正在探索其他經營模式，例如捆綁式服務產品和基於訂閱的主機存取模式，以平穩確認收入並維護客戶關係。從創新角度來看，關稅正在推動對國內製造能力和本地組裝的投資，這可能在長期內增強供應韌性，但也需要謹慎的資本規劃和勞動力發展。最終，累積效應正在加速策略性供應鏈重組，並鼓勵醫療服務提供者和供應商之間採用更具創造性的合約方式。

基於細分市場的深刻洞察，將臨床應用、設備類型、最終使用環境和手術角色與可操作的產品和商業化重點聯繫起來。

深入的細分分析揭示了臨床需求、產品設計和採購優先順序在應用、器械類型、最終用途和手術目的等方面的交匯點。將應用分為冠狀動脈和周邊血管兩大類，並將冠狀動脈類進一步細分為急性冠狀動脈症候群和慢性完全閉塞，將周邊血管類進一步細分為周邊動脈疾病和外周靜脈應用，結果表明，成像需求會因病變複雜程度、血管大小以及是否需要進行縱向血管評估而有所不同。這些臨床差異決定了產品團隊優先考慮的導管形狀、頻率選擇和影像處理功能。

同樣，對設備類型的分析揭示了不同的價值鏈和使用者工作流程。陣列導管和單元件導管的分類反映了影像保真度、每次使用成本和相容性之間的權衡。同時，可攜式和固定式主機的分類突顯了門診和混合主機對移動性的需求，以及醫院導管室對數量和性能的期望。諸如門診手術中心、醫院和研究機構等終端用戶環境，有著獨特的採購週期、資本核准流程和整合要求，這些都會影響資本支出和一次性用品的採購決策。最後，將手術操作分為診斷功能和引導功能（診斷子類別包括管腔測量和斑塊表徵，而引導子類別包括動脈粥狀硬化斑塊切除術輔助和支架置入）有助於明確臨床工作流程和證據需求。診斷應用強調定量可重複性和報告，而引導應用則需要即時視覺化、穩健的導管操控性和與治療設備的整合。整合這些分類軸，可以讓公司優先考慮與特定臨床用例和買家畫像相符的產品特性、臨床檢驗計畫和商業化路徑。

美洲、歐洲、中東和非洲以及亞太地區的採用模式和戰略要務對臨床應用和商業化路徑的影響

區域趨勢對於理解血管內超音波（IVUS）的應用模式和策略重點至關重要。在美洲，臨床上對介入性心臟病學創新的重視、針對複雜手術的完善報銷機制以及高容量中心的集中分佈，都促進了先進成像技術的應用和競爭激烈的服務市場。該地區的監管路徑和採購慣例強調可靠的臨床結果和經證實的成本效益，這影響供應商如何優先考慮臨床證據和上市後監測。

歐洲、中東和非洲地區的醫療格局更為多元化，在醫療資金籌措、先進導管室基礎設施的普及以及區域法規結構等方面存在顯著差異。應對這種多樣性需要採取適應性強的打入市場策略、與當地分銷商建立合作關係以及彈性價格設定方式。亞太地區則以其介入治療能力的快速發展、對本土製造業的投資以及日益活躍的臨床研究活動而聞名。該地區的許多醫療系統正在同步加強三級醫療服務能力，並透過門診服務擴大醫療服務覆蓋範圍，這為可攜式主機和差異化導管設計創造了機會。由於各地區臨床實務模式和採購週期存在差異，因此需要製定個人化的證據產生方案和商業模式，以反映當地支付方的期望和實際運作。

競爭與合作的動態表明，硬體領導企業、利基創新者和軟體參與企業如何塑造血管內超音波(IVUS) 領域的產品差異化和市場定位。

在血管內超音波（IVUS）領域，能夠整合卓越的硬體、軟體驅動的分析能力和強大的臨床支援的機構仍然佔據優勢。現有醫療設備製造商利用規模經濟、深厚的臨床關係和全球分銷網路來維持主導地位，而專業的成像創新者則在影像解析度、導管設計和工作流程整合方面展開競爭。新興參與企業（包括中小型科技公司和軟體開發人員）正透過專注於機器學習驅動的斑塊分析、自動化報告和雲端資料管理來支持多中心註冊研究和上市後證據收集，從而挑戰傳統觀念。

與治療設備製造商簽訂共同開發契約、授權使用先進的訊號處理演算法以及開展基於聯盟的臨床研究以加速指南採納等夥伴關係和戰略合作正變得日益重要。此外，售後服務、訓練項目和手術決策支援工具已成為影響購買決策的差異化因素。成功的公司會平衡研發投入與務實的商業化策略，優先考慮互通性、總體擁有成本以及透過提高手術效率和改善患者預後來提供可證明的臨床價值。

針對製造商和醫療服務提供者的具體策略建議包括：證據產生、互通性、供應鏈韌性和教育計畫。這些措施將整合起來，以加速血管內超音波（IVUS）的普及應用。

血管內超音波（IVUS）生態系統中的領導企業應協調對臨床證據、產品互通性和供應鏈韌性的投資，以掌握血管內成像日益成長的作用。首先，企業應優先進行可操作的臨床研究，以明確血管內超音波何時能顯著改善手術結果，以及對臨床醫師和支付者而言最重要的指標。此類證據的設計應支持指南的採納和醫保報銷的討論。其次，關注開放標準以及與導管室系統、生理測量平台和電子病歷的互通性，將有助於減少推廣應用的障礙，並支持收集長期數據以證明其價值。

在營運方面，供應商應實現組件採購多元化，盡可能投資本地製造夥伴關係關係，並提供靈活的商業模式，例如服務包、計量收費和主機訂閱。培訓仍然至關重要，結合實踐模擬、遠端監控和數據驅動回饋循環的可擴展培訓專案可以加快操作人員的熟練度提升和產品應用。最後，經營團隊應促進與治療設備製造商和軟體公司進行有針對性的合作，共同開發整合動脈粥狀硬化斑塊切除術和支架置入指導的解決方案。這將增強其臨床提案，並為整合程度較低的競爭對手設置進入障礙。

本分析所依據的綜合調查方法結合了臨床醫生和工程師的專業知識、一手研究、二手文獻綜述和技術檢驗，以確保分析的嚴謹性和透明性。

本分析所依據的研究結合了與介入性心臟病專家、血管專家、採購人員和器械工程師進行的初步定性研究，以及對臨床文獻、監管指南和技術評估的嚴格二次審查。初步研究包括結構化訪談和諮詢討論，旨在確定未滿足的臨床需求、手術流程和採購決策標準。這些討論輔以導管設計、感測器架構和主機軟體功能的技術評估，以將產品特性與臨床應用案例相匹配。

二次研究涵蓋了同行評審的臨床研究、指南聲明和監管文件，旨在檢驗臨床療效和安全性，而不進行市場規模估算。研究採用數據三角測量技術整合不同資訊並達成共識，同時清楚記錄證據不足或不均衡領域的限制。整個研究過程透過專家檢驗、對受訪者進行利益衝突篩檢以及遵守有關保密性和知情同意的倫理研究標準，確保了調查方法的嚴謹性。這種方法確保了研究結果基於當代臨床實踐和技術可行性，同時也明確指出了需要進一步前瞻性研究的領域。

摘要重點闡述了血管內超音波向重要影像引導工具轉型的現狀，以及將決定未來主導的策略性舉措。

血管內超音波正處於轉折點，技術成熟度、臨床需求和商業策略正在融合，推動其在心血管和周邊介入治療中發揮更大的作用。該技術提供的「可操作資訊」使其提案超越了單純的解剖成像，成為精準治療計劃和檢驗的基礎。隨著臨床指南和操作者期望的不斷演變，相關人員，將能夠引領該技術的應用普及。

展望未來，區域醫療保健趨勢、供應鏈協調以及軟體驅動的分析之間的相互作用將決定哪些應用和設備配置將最為普及。對互通性和整合式手術解決方案的策略性投資將使企業脫穎而出，而加速臨床檢驗和報銷流程的夥伴關係將釋放更廣泛的臨床效用。簡而言之，血管內超音波（IVUS）正從一種專業輔助手段轉變為介入醫師尋求可重複影像導引治療結果的必備工具。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 大型醫院擴大採用3D和即時容積式血管內超音波系統
  • 利用血管內超音波結合人工智慧演算法實現斑塊自動表徵
  • 開發用於全面評估冠狀動脈病變的混合型血管內超音波-光學相干斷層掃描導管
  • 血管內超音波導引治療在複雜慢性完全閉塞病例的應用日益廣泛
  • 擴展與血管內超音波（IVUS）相容的光纖感測器，實現高解析度影像重現性
  • 設備製造商和軟體公司合作推進血管內超音波（IVUS）影像分析
  • 保險核准核准的增加推動了血管內超音波設備在臨床上的廣泛應用
  • 專注於用於周邊和神經血管應用的小型化IVUS導管

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 血管內超音波市場：依應用領域分類

  • 冠狀動脈
    • 急性冠狀動脈症候群
    • 慢性完全閉塞
  • 外圍
    • 周邊動脈疾病
    • 周邊靜脈應用

9. 血管內超音波市場（按類型分類）

  • 導管
    • 陣列導管
    • 單元件導管
  • 主機
    • 可攜式主機
    • 固定主機

第10章 血管內超音波市場：依最終用途分類

  • 門診手術中心
  • 醫院
  • 研究所

第11章 血管內超音波市場（依手術類型分類）

  • 診斷
    • 管腔測量
    • 斑塊特徵
  • 指導
    • 動脈粥狀硬化斑塊切除術支持
    • 支架置入

第12章 血管內超音波市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 血管內超音波市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國血管內超音波市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Koninklijke Philips NV
    • Boston Scientific Corporation
    • Siemens Healthineers AG
    • General Electric Company
    • Abbott Laboratories
    • Canon Medical Systems Corporation
    • Terumo Corporation
    • ACIST Medical Systems, Inc.
    • InfraReDx, Inc.
Product Code: MRR-F6513A06BEE8

The Intravascular Ultrasound Market is projected to grow by USD 1,380.66 million at a CAGR of 5.33% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 910.95 million
Estimated Year [2025] USD 959.20 million
Forecast Year [2032] USD 1,380.66 million
CAGR (%) 5.33%

Foundational overview of intravascular ultrasound developments and clinical integration shaping procedural decision-making and device selection in contemporary cardiovascular care

Intravascular ultrasound (IVUS) has evolved from an investigational adjunct to a frontline imaging modality that materially influences interventional strategy and device selection. Recent advances in acoustic array technology, higher-resolution imaging modes, and improved catheter designs have narrowed the gap between intravascular imaging and real-time procedural guidance, enabling clinicians to visualize vessel morphology, quantify plaque burden, and optimize device sizing with greater confidence. As a result, IVUS increasingly factors into complex coronary and peripheral interventions, supporting improved procedural precision and potentially better clinical outcomes.

Across care settings, adoption is driven by a combination of clinical evidence, operator training, and equipment accessibility. Technological synergies with complementary modalities, software-enabled analytics for automated measurements, and integration with cath lab workflows are shaping clinician expectations. Simultaneously, regulatory scrutiny and reimbursement pathways continue to influence procurement choices and deployment strategies. Taken together, these factors establish IVUS as both a clinical and commercial focal point for stakeholders seeking to differentiate through imaging-enabled value propositions.

Transformative convergence of higher-resolution imaging, software automation, and clinical evidence generation that is redefining the role of intravascular ultrasound in intervention planning

The IVUS landscape is being reshaped by a convergence of technology innovation, shifting clinical guidelines, and new expectations for procedural outcomes. High-frequency array catheters and improved signal processing algorithms now permit clearer delineation of plaque components and stent apposition, reducing reliance on fluoroscopic inference. Concurrently, enhanced software suites that provide automated lumen and plaque metrics are enabling faster interpretation and consistent reporting across operators, which supports standardized procedural endpoints and comparative outcomes analysis.

Moreover, procedural emphasis has migrated from purely anatomical success to functional and durability metrics, prompting clinicians to integrate IVUS findings with physiological assessments and intraprocedural decision-making. This shift encourages vendors to offer platforms that are interoperable with existing cath lab systems and that support data export for registries and longitudinal follow-up. In parallel, an ecosystem of partnerships between device manufacturers, software developers, and clinical centers is accelerating evidence generation and adoption. Taken together, these transformative shifts are redefining value propositions for IVUS across clinical, operational, and commercial dimensions.

Assessment of how 2025 United States tariff shifts have catalyzed supply chain realignment, sourcing diversification, and alternative commercial models for intravascular ultrasound stakeholders

Tariff adjustments and trade policy changes introduced in the United States in 2025 have exerted a complex influence on procurement, supply chains, and pricing strategies for medical imaging hardware and disposable devices. For IVUS, which relies on precision-engineered catheters, custom transducer materials, and console electronics, increased import duties can elevate landed costs. In response, manufacturers have prioritized regional sourcing diversification, nearshoring of key components, and redesigns that reduce dependency on tariff-affected inputs while preserving clinical performance.

Transitioning supply chains is not instantaneous; lead times for qualification, validation, and regulatory submission impose temporal friction. Consequently, healthcare providers have adopted staged purchasing strategies and longer-term service agreements to mitigate price volatility. At the same time, distributors and OEMs have explored alternative commercial models, including bundled service offerings and subscription-based access to consoles, to smooth revenue recognition and maintain customer relationships. From an innovation perspective, tariffs have incentivized investment in domestic manufacturing capacity and local assembly, which over time may strengthen supply resilience but also require careful capital planning and workforce development. Ultimately, the cumulative impact has been to accelerate strategic supply chain realignment while prompting more creative contracting approaches between providers and vendors.

Compelling segmentation-driven insights that link clinical applications, device typologies, end-use environments, and procedural roles to actionable product and commercialization priorities

Insightful segmentation analysis reveals where clinical demand, product design, and procurement priorities intersect across application, device type, end use, and procedural purpose. When applications are parsed into coronary and peripheral domains, with coronary further distinguished by acute coronary syndrome and chronic total occlusion and peripheral use differentiated into peripheral artery disease and peripheral venous applications, it becomes clear that imaging requirements diverge by lesion complexity, vessel size, and the need for longitudinal vessel assessment. These clinical distinctions drive catheter geometry, frequency selection, and image processing features that product teams prioritize.

Similarly, examining device type illuminates differing value chains and user workflows. Catheters split into array catheters and single element catheters reflect trade-offs between image fidelity, cost per use, and compatibility, while console segmentation into portable and stationary consoles highlights the demand for mobility in ambulatory and hybrid settings versus the capacity and performance expectations in hospital cath labs. End-use environments such as ambulatory surgical centers, hospitals, and research institutes each impose unique procurement cycles, capital approval processes, and integration requirements, which in turn influence decisions on capital expenditure versus disposable purchases. Finally, procedural segmentation into diagnostic and guidance functions-where diagnostic subcategories include lumen measurement and plaque characterization, and guidance subcategories include atherectomy support and stent placement-clarifies clinical workflows and evidence needs. Diagnostic applications emphasize quantitative reproducibility and reporting, while guidance applications demand real-time visualization, robust catheter handling, and integration with therapeutic devices. By synthesizing these axes of segmentation, companies can prioritize product features, clinical validation plans, and commercialization pathways aligned to specific clinical use cases and buyer profiles.

Regional adoption patterns and strategic imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence clinical uptake and commercialization pathways

Regional dynamics are critical to understanding adoption patterns and strategic priorities for IVUS. In the Americas, clinical emphasis on interventional cardiology innovation, well-established reimbursement frameworks for complex procedures, and a concentration of high-volume centers have supported advanced imaging adoption and a competitive service market. Regulatory pathways and procurement practices in the region place a premium on robust clinical outcomes and cost-effectiveness demonstrations, which influences how vendors prioritize clinical evidence and post-market surveillance.

In Europe, Middle East & Africa, the landscape is more heterogeneous, with marked variation in healthcare funding, access to advanced cath lab infrastructure, and local regulatory frameworks. This heterogeneity requires adaptive market entry strategies, partnerships with regional distributors, and flexible pricing approaches. In the Asia-Pacific region, rapid expansion of interventional capabilities, investment in domestic manufacturing, and growing clinical research activity are notable. Many health systems in that region are simultaneously building capacity in tertiary centers and broadening access through ambulatory settings, creating opportunities for both portable consoles and differentiated catheter designs. Across regions, differences in clinical practice patterns and procurement cycles necessitate tailored evidence generation and commercial models that reflect local payer expectations and operational realities.

Competitive and collaborative dynamics showing how hardware leaders, niche innovators, and software entrants are shaping product differentiation and market positioning in intravascular ultrasound

Competitive dynamics in the IVUS space continue to favor organizations that can integrate hardware excellence with software-enabled analytics and strong clinical support. Established medical device firms often leverage scale, deep clinical relationships, and global distribution networks to maintain leadership, while specialized imaging innovators compete on image resolution, catheter design, and workflow integration. Emerging entrants-including small-cap technology firms and software developers-are challenging conventions by focusing on machine learning-driven plaque analysis, automated reporting, and cloud-enabled data management that supports multicenter registries and post-market evidence collection.

Partnerships and strategic collaborations are increasingly important, whether through co-development agreements with therapeutic device manufacturers, licensing of advanced signal-processing algorithms, or consortium-based clinical studies that accelerate guideline inclusion. In addition, aftermarket services, training programs, and procedural decision-support tools have become differentiators that influence purchasing decisions. Successful companies balance investment in R&D with pragmatic commercialization strategies that prioritize interoperability, total cost of ownership considerations, and demonstrable clinical value delivered through improved procedural efficiency and patient outcomes.

Actionable strategic recommendations for manufacturers and providers to align evidence generation, interoperability, supply resilience, and education programs to accelerate intravascular ultrasound adoption

Leaders in the IVUS ecosystem should align investments across clinical evidence, product interoperability, and supply chain resilience to capture the expanding role of intravascular imaging. First, companies must prioritize pragmatic clinical studies that clarify when intravascular ultrasound materially improves procedural outcomes and which metrics matter most to operators and payers; such evidence should be designed to support guideline inclusion and reimbursement discussions. Second, focusing on open standards and interoperability with cath lab systems, physiologic measurement platforms, and electronic health records will lower barriers to adoption and support longitudinal data capture for value demonstration.

Operationally, vendors should diversify component sourcing, invest in regional manufacturing partnerships where feasible, and offer flexible commercial models that include service bundles, pay-per-use, or subscription options for consoles. Training and education remain critical; therefore, scalable programs that combine hands-on simulation, remote proctoring, and data-driven feedback loops will accelerate operator proficiency and adoption. Finally, executives should pursue targeted collaborations with therapeutic device manufacturers and software firms to co-create integrated solutions for guidance during atherectomy and stent placement, thereby strengthening clinical propositions and creating barrier-to-entry effects against less integrated competitors.

Comprehensive research methodology blending primary clinician and engineering insights with secondary literature review and technical validation to ensure rigorous, transparent analysis

The research underpinning this analysis synthesizes primary qualitative engagement with interventional cardiologists, vascular specialists, procurement leaders, and device engineers alongside rigorous secondary review of clinical literature, regulatory guidance, and technology assessments. Primary inputs included structured interviews and advisory discussions designed to uncover unmet clinical needs, procedural workflows, and procurement decision criteria. These conversations were complemented by technical assessments of catheter designs, transducer architectures, and console software capabilities to map product feature sets against clinical use cases.

Secondary research included peer-reviewed clinical studies, guideline statements, and regulatory documentation to validate clinical efficacy and safety considerations without extrapolating market volumes. Data triangulation techniques were applied to reconcile disparate inputs and surface consensus views, while limitations were clearly documented where evidence is emerging or heterogeneous. Throughout the process, methodological rigor was maintained through expert validation rounds, conflict-of-interest screening for interview participants, and adherence to ethical research standards for confidentiality and informed consent. This approach ensures that findings are grounded in contemporary clinical practice and technical feasibility while being transparent about areas that warrant further prospective study.

Concluding synthesis that highlights intravascular ultrasound's transition to an indispensable image-guided tool and the strategic actions that determine future leadership

Intravascular ultrasound stands at an inflection point where technological maturity, clinical expectations, and commercial strategy converge to expand its role in cardiovascular and peripheral interventions. The modality's capacity to provide actionable intraprocedural information has elevated its value proposition beyond anatomical imaging to a cornerstone of precision therapy planning and verification. As clinical guidelines and operator expectations evolve, stakeholders who align product innovation with pragmatic evidence generation, robust training, and flexible commercial models will be positioned to lead adoption curves.

Looking forward, the interplay of regional healthcare dynamics, supply chain adjustments, and software-driven analytics will determine which applications and device configurations gain the most traction. Strategic investments in interoperability and integrated procedural solutions will differentiate winners from followers, while partnerships that accelerate clinical validation and reimbursement pathways will unlock broader clinical utility. In sum, IVUS is transitioning from a specialized adjunct to an indispensable tool for interventionalists seeking reproducible, image-guided outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of 3D and real-time volumetric IVUS systems by leading hospitals
  • 5.2. Integration of artificial intelligence algorithms for automated plaque characterization using IVUS
  • 5.3. Development of hybrid IVUS-OCT catheters for comprehensive coronary lesion assessment
  • 5.4. Growing utilization of IVUS guidance in complex chronic total occlusion interventions
  • 5.5. Expansion of IVUS-compatible fiber-optic sensors enabling higher resolution imaging fidelity
  • 5.6. Partnerships between device manufacturers and software firms to enhance IVUS image analysis
  • 5.7. Increasing reimbursement approvals driving broader clinical adoption of IVUS devices
  • 5.8. Focus on miniaturized IVUS catheters for peripheral vascular and neurovascular applications

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intravascular Ultrasound Market, by Application

  • 8.1. Coronary
    • 8.1.1. Acute Coronary Syndrome
    • 8.1.2. Chronic Total Occlusion
  • 8.2. Peripheral
    • 8.2.1. Peripheral Artery Disease
    • 8.2.2. Peripheral Venous Applications

9. Intravascular Ultrasound Market, by Type

  • 9.1. Catheters
    • 9.1.1. Array Catheters
    • 9.1.2. Single Element Catheters
  • 9.2. Consoles
    • 9.2.1. Portable Consoles
    • 9.2.2. Stationary Consoles

10. Intravascular Ultrasound Market, by End Use

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
  • 10.3. Research Institutes

11. Intravascular Ultrasound Market, by Procedure

  • 11.1. Diagnostic
    • 11.1.1. Lumen Measurement
    • 11.1.2. Plaque Characterization
  • 11.2. Guidance
    • 11.2.1. Atherectomy Support
    • 11.2.2. Stent Placement

12. Intravascular Ultrasound Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Intravascular Ultrasound Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Intravascular Ultrasound Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Koninklijke Philips N.V.
    • 15.3.2. Boston Scientific Corporation
    • 15.3.3. Siemens Healthineers AG
    • 15.3.4. General Electric Company
    • 15.3.5. Abbott Laboratories
    • 15.3.6. Canon Medical Systems Corporation
    • 15.3.7. Terumo Corporation
    • 15.3.8. ACIST Medical Systems, Inc.
    • 15.3.9. InfraReDx, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. INTRAVASCULAR ULTRASOUND MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. INTRAVASCULAR ULTRASOUND MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INTRAVASCULAR ULTRASOUND MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL VENOUS APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL VENOUS APPLICATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL VENOUS APPLICATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL VENOUS APPLICATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL VENOUS APPLICATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL VENOUS APPLICATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ARRAY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ARRAY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ARRAY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ARRAY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ARRAY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ARRAY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SINGLE ELEMENT CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SINGLE ELEMENT CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SINGLE ELEMENT CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SINGLE ELEMENT CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SINGLE ELEMENT CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SINGLE ELEMENT CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PORTABLE CONSOLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PORTABLE CONSOLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PORTABLE CONSOLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PORTABLE CONSOLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PORTABLE CONSOLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PORTABLE CONSOLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STATIONARY CONSOLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STATIONARY CONSOLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STATIONARY CONSOLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STATIONARY CONSOLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STATIONARY CONSOLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STATIONARY CONSOLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY LUMEN MEASUREMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY LUMEN MEASUREMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY LUMEN MEASUREMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY LUMEN MEASUREMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY LUMEN MEASUREMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY LUMEN MEASUREMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PLAQUE CHARACTERIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PLAQUE CHARACTERIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PLAQUE CHARACTERIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PLAQUE CHARACTERIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PLAQUE CHARACTERIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PLAQUE CHARACTERIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ATHERECTOMY SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ATHERECTOMY SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ATHERECTOMY SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ATHERECTOMY SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ATHERECTOMY SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ATHERECTOMY SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STENT PLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STENT PLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STENT PLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STENT PLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STENT PLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STENT PLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 291. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 292. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 293. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 296. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 297. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2018-2024 (USD MILLION)
  • TABLE 298. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2025-2032 (USD MILLION)
  • TABLE 299. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 300. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 301. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 302. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 303. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 304. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 305. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 306. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 312. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 313. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 314. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 315. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2025-2032 (